Evidence map›Paper›PMID 36445367›Full record

ArticleJournal of clinical microbiology2022

A Nationwide Plasmidome Surveillance in Thailand Reveals a Limited Variety of New Delhi Metallo-β-Lactamase-Producing Carbapenem-Resistant

Ryuichiro Abe, Yukihiro Akeda, Noriko Sakamoto, Dan Takeuchi, Yo Sugawara, Norihisa Yamamoto, Anusak Kerdsin, Yuki Matsumoto, Daisuke Motooka, Warawut Laolerd and 6 more

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Emergence of blaBMC microbiology · 2026
    Article
  2. Article
  3. Article
  4. ConfrontingInfection and drug resistance · 2026
    Review
  5. The Emergence ofAntibiotics (Basel, Switzerland) · 2025
    Article
  6. Risk factors, and outcomes of patients with carbapenem-resistantFrontiers in cellular and infection microbiology · 2025
    Article
  7. Article
  8. Article
  9. Antimicrobial agents and chemotherapy · 2024
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Ryuichiro AbeJapan-Thailand Research Collaboration Center on Emerging and Re-emerging Infections, Research Institute for Microbial Diseases, Osaka Universitygrid.136593.b, Osaka, Japan.ORCID 0000-0001-9907-1180
Yukihiro AkedaJapan-Thailand Research Collaboration Center on Emerging and Re-emerging Infections, Research Institute for Microbial Diseases, Osaka Universitygrid.136593.b, Osaka, Japan.ORCID 0000-0002-5325-4173
Noriko SakamotoJapan-Thailand Research Collaboration Center on Emerging and Re-emerging Infections, Research Institute for Microbial Diseases, Osaka Universitygrid.136593.b, Osaka, Japan.
Dan TakeuchiJapan-Thailand Research Collaboration Center on Emerging and Re-emerging Infections, Research Institute for Microbial Diseases, Osaka Universitygrid.136593.b, Osaka, Japan.
Yo SugawaraJapan-Thailand Research Collaboration Center on Emerging and Re-emerging Infections, Research Institute for Microbial Diseases, Osaka Universitygrid.136593.b, Osaka, Japan.
Norihisa YamamotoDepartment of Infection Control and Prevention, Graduate School of Medicine, Osaka Universitygrid.136593.b, Osaka, Japan.
Anusak KerdsinFaculty of Public Health, Kasetsart University Chalermphrakiat Sakon Nakhon Province Campus, Sakon Nakhon, Thailand.ORCID 0000-0003-1055-3656
Yuki MatsumotoDepartment of Infection Metagenomics, Research Institute for Microbial Diseases, Osaka Universitygrid.136593.b, Osaka, Japan.
Daisuke MotookaDepartment of Infection Metagenomics, Research Institute for Microbial Diseases, Osaka Universitygrid.136593.b, Osaka, Japan.
Warawut LaolerdFaculty of Medicine Ramathibodi Hospital, Mahidol Universitygrid.10223.32, Bangkok, Thailand.
Pitak SantanirandFaculty of Medicine Ramathibodi Hospital, Mahidol Universitygrid.10223.32, Bangkok, Thailand.
Masato SuzukiAntimicrobial Resistance Research Center, National Institute of Infectious Diseasesgrid.410795.e, Tokyo, Japan.ORCID 0000-0001-8975-2193
Keigo ShibayamaDepartment of Bacteriology II, National Institute of Infectious Diseasesgrid.410795.e, Tokyo, Japan.
Kazunori TomonoDepartment of Infection Control and Prevention, Graduate School of Medicine, Osaka Universitygrid.136593.b, Osaka, Japan.
Tetsuya IidaJapan-Thailand Research Collaboration Center on Emerging and Re-emerging Infections, Research Institute for Microbial Diseases, Osaka Universitygrid.136593.b, Osaka, Japan.ORCID 0000-0001-5134-1794
Shigeyuki HamadaJapan-Thailand Research Collaboration Center on Emerging and Re-emerging Infections, Research Institute for Microbial Diseases, Osaka Universitygrid.136593.b, Osaka, Japan.
The University of Osaka · JPNational Institute of Infectious Diseases · JPMahidol University · THKasetsart University · THOsaka International Cancer Institute · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite frequent identification of plasmids carrying carbapenemase genes, the transfer of plasmids carrying carbapenemase genes is not well recognized in clinical settings because of technical limitations. To investigate the detailed mechanisms of the spread of carbapenem-resistant

Indexed as

Carbapenem-Resistant EnterobacteriaceaeEnterobacteriaceae InfectionsAnti-Bacterial Agentsbeta-LactamasesEnterobacteriaceaeEscherichia coliHumansKlebsiella pneumoniaeMicrobial Sensitivity TestsPlasmidsThailandAnti-Bacterial Agentsbeta-lactamase NDM-1beta-Lactamasescarbapenemasecarbapenemase-producing Enterobacteralescarbapenem-resistant Enterobacteralesnationwide studyNDMplasmid analysisplasmidome

Identifiers

PMID36445367
PMCPMC9769800
OpenAlexW4310282145

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.